APOE epsilon 4 moderates amyloid-related memory decline in preclinical Alzheimer's disease

Yen Ying Lim; Victor L Villemagne; Robert H Pietrzak; David Ames; Kathryn A Ellis; Karra Harrington; Peter J Snyder; Ralph N Martins; Colin L Masters; Christopher C Rowe; Paul Maruff

Journal article

APOE epsilon 4 moderates amyloid-related memory decline in preclinical Alzheimer's disease

Yen Ying Lim, Victor L Villemagne, Robert H Pietrzak, David Ames, Kathryn A Ellis, Karra Harrington, Peter J Snyder, Ralph N Martins, Colin L Masters, Christopher C Rowe, Paul Maruff

Neurobiology of Aging | ELSEVIER SCIENCE INC | Published : 2015

DOI: 10.1016/j.neurobiolaging.2014.12.008

University of Melbourne Researchers

Yen Ying Lim Author Florey Department of Neuroscience and Mental Health

Kathryn Ellis Author Psychiatry

Colin Masters Author Florey Department of Neuroscience and Mental Health

Christopher Rowe Author Florey Department of Neuroscience and Mental Health

David Ames Author Psychiatry

Grants

Funding Acknowledgements

Funding for the study was provided in part by the study partners [Australian Commonwealth Scientific Industrial and research Organization (CSIRO), Edith Cowan University (ECU), Mental Health Research Institute (MHRI), Alzheimer's Australia (AA), National Ageing Research Institute (NARI), Austin Health, CogState Ltd, Hollywood Private Hospital, and Sir Charles Gardner Hospital. The study also received support from the National Health and Medical Research Council (NHMRC) and the Dementia Collaborative Research Centres program (DCRC2), as well as ongoing funding from the Science and Industry Endowment Fund (SIEF). The authors also acknowledge the financial support of the Cooperative Research Centre (CRC) for Mental Health, from the Australian Government.